← Back to Search

e-Psychotherapy for Mental Health Issues

N/A
Waitlist Available
Led By Nazanin Alavi, MD
Research Sponsored by Dr. Nazanin Alavi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
Awards & highlights

Study Summary

This trial aims to develop an AI-driven online mental health hub for post-secondary students to deliver accessible, cost-effective and efficacious mental health care.

Who is the study for?
This trial is for post-secondary students who can speak and read English, are enrolled in certain institutions, can consent to participate, and have reliable internet access. It's designed to help those facing mental health challenges.Check my eligibility
What is being tested?
The study tests an AI-driven online mental health care hub offering psychoeducation and e-CBT specifically tailored for post-secondary students. The effectiveness of this virtual support system will be compared with traditional treatments.See study design
What are the potential side effects?
Since the interventions involve non-invasive e-psychotherapy and psychoeducation, side effects may include discomfort from confronting personal issues or fatigue from screen time but no physical side effects like with medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 0, 3, 6, follow-up 1, 2, 3, 4, 5, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in ADHD severity (ASRS)
Change in anxiety severity (GAD-7)
Change in depression severity (PHQ-9)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: e-PsychotherapyExperimental Treatment1 Intervention
Participants in the treatment group will receive access to the hub's services which begin with six weeks of online psychoeducation. Participants will be recruited through on-campus flyers, advertisements and wellness-center announcements, media advertisements, expert end-user referrals, and self-referrals. Participants will be excluded if they have active psychosis, acute mania, and/or active suicidal or homicidal ideation, and have received psychoeducation or psychotherapy like that offered by our proposed hub in the past six months. Participants with high disorder severity will be referred to other community resources determined by clinicians and therapists on the research team.
Group II: Treatment as UsualActive Control1 Intervention
TAU will consist of medications, regular physician or clinician visits, referrals or consultations that are conducted outside of the current research study.

Find a Location

Who is running the clinical trial?

Dr. Nazanin AlaviLead Sponsor
12 Previous Clinical Trials
1,116 Total Patients Enrolled
3 Trials studying Mental Health Issue
219 Patients Enrolled for Mental Health Issue
Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,417 Total Patients Enrolled
3 Trials studying Mental Health Issue
219 Patients Enrolled for Mental Health Issue
Nazanin Alavi, MDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

e-Psychotherapy/Psychoeducation Clinical Trial Eligibility Overview. Trial Name: NCT05754723 — N/A
Mental Health Issue Research Study Groups: e-Psychotherapy, Treatment as Usual
Mental Health Issue Clinical Trial 2023: e-Psychotherapy/Psychoeducation Highlights & Side Effects. Trial Name: NCT05754723 — N/A
e-Psychotherapy/Psychoeducation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05754723 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this experiment still open?

"According to clinicaltrials.gov, this investigation is no longer recruiting patients as the last edit was on February 22nd 2023. Nonetheless, there are still 56 other medical trials actively seeking volunteers at the moment."

Answered by AI
~0 spots leftby Apr 2025